Rituximab (R) Versus Non-Rituximab (NR) Containing Reduced Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) in B-Cell Non-Hodgkin Lymphomas (B-NHL): A CIBMTR Analysis | Publicación